43 companies, 1 interpreter! Insight, foresight
and recommendation 



Regulatory initiatives form the bridge between important discoveries and opportunities in science, and the real world products; it supports and shapes the development of new and better drugs, vaccines and diagnostics, as well as more efficient processes to evaluate medical products and get them to market.

In actuality, regulation—when it’s done right—whether in the Americas, Europe, Africa, or Asia – shouldn’t be a roadblock, but rather a facilitative pathway to achieve meaningful and lasting innovation for the public good. Regulation – when it’s done right – should not only help protect and promote the health of a community, but it also should help advance stability and economic health.

But even those who recognize the essential role of regulators like FDA may not appreciate that the fragmentation and globalization of product development and production, and the flow of components and finished goods across borders, are forcing a paradigm shift in the way regulators fulfill their mission within their own jurisdictions.